Scarica l'app Stockscreener
0.77
3.89%
-0.03
Precedente Chiudi:
$0.80
Aprire:
$0.8
Volume 24 ore:
415.24K
Relative Volume:
0.94
Capitalizzazione di mercato:
$39.55M
Reddito:
$107.88M
Utile/perdita netta:
$-33.52M
Rapporto P/E:
-1.1479
EPS:
-0.6708
Flusso di cassa netto:
$-11.94M
1 W Prestazione:
-8.39%
1M Prestazione:
-63.04%
6M Prestazione:
-79.05%
1 anno Prestazione:
-62.31%
Intervallo 1D:
$0.7601
$0.808
Intervallo di 1 settimana:
$0.7601
$0.8897
Portata 52W:
$0.68
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Nome
Mdxhealth Sa
Settore
Industria
Telefono
-
Indirizzo
-
Compare MDXH vs TMO, DHR, IDXX, WAT, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.77 | 41.09M | 107.88M | -33.52M | -11.94M | -0.6708 |
TMO
Thermo Fisher Scientific Inc
|
448.84 | 166.59B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.25 | 121.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.97 | 44.12B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.06 | 33.62B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.33 | 32.49B | 7.07B | 1.29B | 993.00M | 4.5355 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-17 | Iniziato | Craig Hallum | Buy |
| 2024-10-31 | Iniziato | Lake Street | Buy |
| 2023-05-31 | Iniziato | TD Cowen | Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
Mdxhealth Sa Borsa (MDXH) Ultime notizie
MDxHealth to Shut Down Resolve UTI Business - Orange County Business Journal
MDxHealth SA (MDXH) Stock Analysis: -3.98% Loss — Key Levels 2026-05-21Fair Value Gap - Newser
Mdxhealth Refocuses on Prostate Franchise Amid Headwinds - The Globe and Mail
MDxHealth SA (MDXH) Stock Analysis: +4.85% Gain — What to Watch 2026-05-20Momentum ETF - Newser
Earnings call transcript: MDxHealth Q1 2026 sees significant stock drop amid earnings miss - Investing.com
MDxHealth SA (MDXH) Slips -1.62%, Testing $0.84 Support 2026-05-18Verified Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Earnings: Miss Sparks ConcernCrowd Trend Signals - Newser
MDxHealth SA (MDXH) Q1 2026 Results Fall Short — EPS $-0.17, Revenue $N/ADividend Cut Risk - Newser
MDxHealth SA stock (US55278X1072): cancer diagnostics specialist back in focus after capital raise - AD HOC NEWS
MDxHealth SA (MDXH) Q1 2026 Earnings Miss: EPS $-0.19 vs $-0.15 Expected - Newser
MDxHealth Exits UTI Business Amid Medicare Reimbursement Dispute - HarianBasis.co
MDxHealth S.A. (NASDAQ:MDXH) Q1 2026 Earnings Call Transcript - Insider Monkey
MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns - simplywall.st
MDXH Sets New Revenue Forecast Excluding Resolve, Anticipates St - GuruFocus
MDXH Maintained by Lake Street -- Price Target Lowered to $5.00 - GuruFocus
Mdxhealth Earnings Call: Prostate Pivot Amid Pressure - TipRanks
MDXH Maintained by TD Cowen -- Price Target Lowered to $1.50 - GuruFocus
MDXH Faces Challenges Amid Strategic Revisions and Medicare Disp - GuruFocus
MDxHealth SA Stock 12‑Month Price Target Cut to $3.9, Implies 100% Upside - TradingView
MDxHealth to exit the Resolve mdx business - TipRanks
MDxHealth price target lowered to $4 from $7 at BTIG - TipRanks
MDxHealth SA Stock 12‑Month Price Target Cut to $4.7, Implies 141% Upside - TradingView
TD Cowen cuts MDxHealth stock price target on Medicare dispute By Investing.com - Investing.com Australia
TD Cowen cuts MDxHealth stock price target on Medicare dispute - Investing.com
MDXH Maintained by BTIG -- Price Target Lowered to $4.00 - GuruFocus
Dow Jumps Over 250 Points; US Retail Sales Increase In April - Benzinga
MDxHealth SA stock (US55278X1072): Strong Q1 results amid strategic shift - AD HOC NEWS
MDxHealth SA Stock 12‑Month Price Target Cut to $5.7, Implies 192% Upside - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $6.8, Implies 249% Upside - TradingView
MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Su - GuruFocus
MDxHealth Q1 Earnings Call Highlights - Inkl
Mdxhealth exits Texas Resolve lab after $10.4M Medicare recoupment - Stock Titan
MDXH Reports Strong Q1 Results Amid Strategic Business Changes - GuruFocus
MDXH: Exited UTI business, focusing on AI-driven prostate cancer diagnostics with 20–26% growth outlook - TradingView
MDXH: Exited UTI business, core cancer revenue up 11%, 2026 guidance set at $110–$115 million - TradingView
Earnings call transcript: MDxHealth Q1 2026 results miss forecasts, stock steady - Investing.com
Mdxhealth Exits Resolve Business, Refocuses on Prostate Cancer as Q1 2026 Revenue Rises 13% - TipRanks
MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Mdxhealth reports Q1-2026 results - marketscreener.com
MDxHealth (NASDAQ: MDXH) posts Q1 2026 growth and issues new 2026 guidance - Stock Titan
Mdxhealth Reports Q1-2026 Results - The Manila Times
MDxHealth reports Q1 EPS (17c) vs. (19c) last year - TipRanks
MSN Money - MSN
MDxHealth SA expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Number of shareholders of MDxHealth SA – NASDAQ:MDXH - TradingView
MDXH SEC FilingsMdxhealth Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Press Release: Mdxhealth to Release First Quarter 2026 Financial Results on May 13 - Moomoo
Mdxhealth Sa Azioni (MDXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):